Home / 2024 (Page 46)

Entod Pharmaceuticals has announced that it has received final approval from the Drug Controller General of India (DCGI) for its groundbreaking PresVu eye drops. This approval, disclosed during a press conference held today in New Delhi, follows a favorable recommendation by the Subject Expert Committee

READ MORE

Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and innovation, today announced the appointment of Bharath Sesha as Managing Director for the Philips Indian subcontinent, effective September 1, 2024. In this role, Bharath will spearhead Philips' growth strategy in India, with a strong

READ MORE

Jupiter Hospital, a leading tertiary care provider in Pune, recently hosted the Jupiter Administration Symposium for Progress, Excellence, and Reform (JASPER 2024). This event brought together healthcare professionals, students, and experts to reimagine hospital management through innovative solutions and collaborative efforts. JASPER 2024 spanned two impactful

READ MORE

Striving to meet the growing demand for high-quality healthcare services in the community Aakash Healthcare, a leader in patient-centric care celebrates its 7th anniversary with a significant expansion, adding 100 new beds to its facility. This development strengthens the hospital's commitment to delivering exceptional healthcare

READ MORE

Since July 2023 only 14 serious international complaints received , being future ready for coming winter season more than 8000 batches of cough syrup tested and only 2-3 per cent failures found  The Central Drugs Standard Control Organization (CDSCO) announced a low failure rate of just

READ MORE

Dr. Nishith Modi - Consultant, Surgical oncology, HCG Cancer Hospital, Vadodara. Maintaining the health of your kidneys is crucial for overall well-being. These essential organs are crucial for filtering waste, maintaining fluid balance, and regulating blood pressure. Your lifestyle choices greatly influence kidney function and overall

READ MORE

  Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to market Scopolamine Transdermal System 1 mg/3 days. (USRLD: Transderm Scop Transdermal System ® 1 mg/3 days). This is the

READ MORE

Pune based, Serigen Mediproducts, a unique biomedical products manufacturing company has raised INR 10 crores from IAN Alpha Fund & Colossa Ventures, along with existing and new angel investors. This significant financial boost will be instrumental in furthering the company’s mission to revolutionize regenerative medicine.

READ MORE

 

 
MedgateToday

Every major healthcare update,
delivered to your inbox

Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.

 

🔒 No spam. Unsubscribe anytime.